Wedbush Reiterates Buy Rating on Bed Bath & Beyond
Wedbush analyst Michael Piccolo maintains a 'buy' rating and sets a $10 target for Bed Bath & Beyond, a 49.25% upside from the current price.
Key Points
- Wedbush's Michael Piccolo reiterated a 'buy' rating on Bed Bath & Beyond, setting a $10 price target on June 23, 2026.
- Wedbush's $10 price target implies 49.25% upside from Bed Bath & Beyond, Inc.'s ($BBBY) current $6.70 share price.
- Bed Bath & Beyond shares traded near $5.83 on Tuesday, with a market cap of about $434.3 million and a 52-week range of $4.26 to $12.65.
- Tidal Investments LLC increased its stake by 289,761 shares, while Vanguard Capital Management LLC opened a new position with 3,043,026 shares.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
On June 23, 2026, Wedbush analyst Michael Piccolo reiterated a 'buy' rating for Bed Bath & Beyond, Inc. (NYSE:BBBY), maintaining a price target of $10. This comes as the company's shares traded near $5.83 on Tuesday.
Wedbush vs. the S&P 500
Hypothetical, simulated performance of disclosed positions vs. the S&P 500. Not realized profit and not investment advice. Past performance does not indicate future results. Details.
Other Institutional Activity in Bed Bath & Beyond
Tidal Investments LLC grew its holdings by 289,761 shares, ending with 6,039,111 shares valued at about $28.0 million. BlackRock, Inc. added 24,694 shares, bringing its total to 4,900,192 shares worth approximately $22.7 million. Vanguard Capital Management LLC opened a new position, acquiring 3,043,026 shares valued at around $14.1 million. Morgan Stanley increased its stake by 206,328 shares, holding 2,644,880 shares valued at about $12.3 million. Meanwhile, Marshall Wace, LLP significantly increased its position by 2,144,353 shares, now holding 2,600,775 shares worth approximately $12.1 million.
Bed Bath & Beyond, Inc. Stock Up 54.0%
Shares of NYSE:BBBY traded near $5.83 on Tuesday. Bed Bath & Beyond has a market cap of about $434.3 million. The stock has a 52-week low of $4.26 and a high of $12.65. Its 50-day moving average is $5.47, and the 200-day moving average is $6.49. The company is not currently profitable, as indicated by its negative forward P/E ratio of -13.06.
$BBBY price target
Past daily closes and this analyst's 12-month price target. Not investment advice.
Insider Buying and Selling at Bed Bath & Beyond, Inc.
On June 4, 2026, Joanna Burkey sold 9,943 shares at an average price of $6.38 as part of a planned transaction. On May 15, 2026, Tamara Ward bought 36,105 shares, while Robert Jacob Shapiro sold and bought 26,873 shares. Barclay Corbus and Debra Golding Perelman also purchased 26,873 shares each on the same day.
Analysts Set New Price Targets
On June 23, 2026, Wedbush maintained its 'buy' rating with a $10 price target. Previously, on April 28, 2026, Wedbush also maintained a 'buy' rating, setting an $8 target. The consensus among analysts is a 'buy' rating with a mean price target of $9.75, based on four analyst opinions.
About Bed Bath & Beyond
Bed Bath & Beyond, Inc., headquartered in the United States, operates a chain of retail stores selling domestic merchandise and home furnishings. The company offers a wide range of products, including bedding, bath items, kitchen textiles, and home decor. With a focus on providing quality products at competitive prices, Bed Bath & Beyond serves customers across North America.
Bottom Line
Wedbush's reiteration of a 'buy' rating and $10 target for Bed Bath & Beyond highlights ongoing interest from institutional investors. The stock's current trading level and recent insider transactions offer insights into market sentiment. Investors often track such activity to assess potential future performance, though it's important to note that analyst ratings and 13F filings are backward-looking and may not reflect current conditions.
Get Bed Bath & Beyond, Inc. alerts
New 13F filings, insider trades, and analyst moves on $BBBY, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.